249 related articles for article (PubMed ID: 35273517)
1. mt tRFs, New Players in MELAS Disease.
Meseguer S; Rubio MP
Front Physiol; 2022; 13():800171. PubMed ID: 35273517
[TBL] [Abstract][Full Text] [Related]
2. The MELAS mutation m.3243A>G alters the expression of mitochondrial tRNA fragments.
Meseguer S; Navarro-González C; Panadero J; Villarroya M; Boutoual R; Sánchez-Alcázar JA; Armengod ME
Biochim Biophys Acta Mol Cell Res; 2019 Sep; 1866(9):1433-1449. PubMed ID: 31195049
[TBL] [Abstract][Full Text] [Related]
3. The MELAS mutation m.3243A>G promotes reactivation of fetal cardiac genes and an epithelial-mesenchymal transition-like program via dysregulation of miRNAs.
Meseguer S; Panadero J; Navarro-González C; Villarroya M; Boutoual R; Comi GP; Armengod ME
Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):3022-3037. PubMed ID: 29928977
[TBL] [Abstract][Full Text] [Related]
4. The ROS-sensitive microRNA-9/9* controls the expression of mitochondrial tRNA-modifying enzymes and is involved in the molecular mechanism of MELAS syndrome.
Meseguer S; Martínez-Zamora A; García-Arumí E; Andreu AL; Armengod ME
Hum Mol Genet; 2015 Jan; 24(1):167-84. PubMed ID: 25149473
[TBL] [Abstract][Full Text] [Related]
5. Correction of the consequences of mitochondrial 3243A>G mutation in the MT-TL1 gene causing the MELAS syndrome by tRNA import into mitochondria.
Karicheva OZ; Kolesnikova OA; Schirtz T; Vysokikh MY; Mager-Heckel AM; Lombès A; Boucheham A; Krasheninnikov IA; Martin RP; Entelis N; Tarassov I
Nucleic Acids Res; 2011 Oct; 39(18):8173-86. PubMed ID: 21724600
[TBL] [Abstract][Full Text] [Related]
6. Pioglitazone and Deoxyribonucleoside Combination Treatment Increases Mitochondrial Respiratory Capacity in m.3243A>G MELAS Cybrid Cells.
Burgin HJ; Lopez Sanchez MIG; Smith CM; Trounce IA; McKenzie M
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32244971
[TBL] [Abstract][Full Text] [Related]
7. Modeling Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes Syndrome Using Patient-Derived Induced Neurons Generated by Direct Reprogramming.
Povea-Cabello S; Villanueva-Paz M; Villalón-García I; Talaverón-Rey M; Álvarez-Cordoba M; Suárez-Rivero JM; Montes MÁ; Rodríguez-Moreno A; Andrade-Talavera Y; Armengol JA; Sánchez-Alcázar JA
Cell Reprogram; 2022 Oct; 24(5):294-303. PubMed ID: 35802497
[TBL] [Abstract][Full Text] [Related]
8. Exploring the Ability of LARS2 Carboxy-Terminal Domain in Rescuing the MELAS Phenotype.
Capriglia F; Rizzo F; Petrosillo G; Morea V; d'Amati G; Cantatore P; Roberti M; Loguercio Polosa P; Bruni F
Life (Basel); 2021 Jul; 11(7):. PubMed ID: 34357047
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes with an
Zheng H; Zhang X; Tian L; Liu B; He X; Wang L; Ding S; Guo Y; Cai J
Front Neurosci; 2022; 16():1028762. PubMed ID: 36685235
[TBL] [Abstract][Full Text] [Related]
10. The Expression Pattern of tRNA-Derived Small RNAs in Adult
Yang D; Xiao F; Yuan Y; Li J; Wang S; Fan X; Ni Q; Li Y; Zhang M; Gu X; Yan T; Yang M; He Z
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047149
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial haplotype mutation alleviates respiratory defect of MELAS by restoring taurine modification in tRNA with 3243A > G mutation.
Ueda S; Yagi M; Tomoda E; Matsumoto S; Ueyanagi Y; Do Y; Setoyama D; Matsushima Y; Nagao A; Suzuki T; Ide T; Mori Y; Oyama N; Kang D; Uchiumi T
Nucleic Acids Res; 2023 Aug; 51(14):7480-7495. PubMed ID: 37439353
[TBL] [Abstract][Full Text] [Related]
12. Screening of effective pharmacological treatments for MELAS syndrome using yeasts, fibroblasts and cybrid models of the disease.
Garrido-Maraver J; Cordero MD; Moñino ID; Pereira-Arenas S; Lechuga-Vieco AV; Cotán D; De la Mata M; Oropesa-Ávila M; De Miguel M; Bautista Lorite J; Rivas Infante E; Alvarez-Dolado M; Navas P; Jackson S; Francisci S; Sánchez-Alcázar JA
Br J Pharmacol; 2012 Nov; 167(6):1311-28. PubMed ID: 22747838
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells.
Pek NMQ; Phua QH; Ho BX; Pang JKS; Hor JH; An O; Yang HH; Yu Y; Fan Y; Ng SY; Soh BS
Cell Death Dis; 2019 Oct; 10(11):802. PubMed ID: 31641105
[TBL] [Abstract][Full Text] [Related]
14. MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options.
El-Hattab AW; Adesina AM; Jones J; Scaglia F
Mol Genet Metab; 2015; 116(1-2):4-12. PubMed ID: 26095523
[TBL] [Abstract][Full Text] [Related]
15. Small RNA-seq and clinical evaluation of tRNA-derived fragments in multiple myeloma: Loss of mitochondrial i-tRF
Soureas K; Papadimitriou MA; Malandrakis P; Papanota AM; Adamopoulos PG; Ntanasis-Stathopoulos I; Liacos CI; Gavriatopoulou M; Sideris DC; Kastritis E; Dimopoulos MA; Scorilas A; Terpos E; Avgeris M
Br J Haematol; 2024 May; 204(5):1790-1800. PubMed ID: 38414235
[TBL] [Abstract][Full Text] [Related]
16. Molecular pathology of MELAS and L-arginine effects.
Koga Y; Povalko N; Nishioka J; Katayama K; Yatsuga S; Matsuishi T
Biochim Biophys Acta; 2012 May; 1820(5):608-14. PubMed ID: 21944974
[TBL] [Abstract][Full Text] [Related]
17. Identification of a Novel Variant in
Xu M; Kopajtich R; Elstner M; Wang Z; Liu Z; Wang J; Prokisch H; Fang F
Front Genet; 2021; 12():638749. PubMed ID: 34054915
[TBL] [Abstract][Full Text] [Related]
18. Expression of tiRNA and tRF in
Lu H; Liu L; Han S; Wang B; Qin J; Bu K; Zhang Y; Li Z; Ma L; Tian J; Zhang K; Li T; Cui H; Liu X
Ann Transl Med; 2021 Sep; 9(18):1457. PubMed ID: 34734009
[TBL] [Abstract][Full Text] [Related]
19. MELAS Syndrome and Kidney Disease Without Fanconi Syndrome or Proteinuria: A Case Report.
Rudnicki M; Mayr JA; Zschocke J; Antretter H; Regele H; Feichtinger RG; Windpessl M; Mayer G; Pölzl G
Am J Kidney Dis; 2016 Dec; 68(6):949-953. PubMed ID: 27683045
[TBL] [Abstract][Full Text] [Related]
20. Detection rates and phenotypic spectrum of m.3243A>G in the MT-TL1 gene: a molecular diagnostic laboratory perspective.
Chin J; Marotta R; Chiotis M; Allan EH; Collins SJ
Mitochondrion; 2014 Jul; 17():34-41. PubMed ID: 24846800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
